Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

RouteOne

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$125M
Portfolio companies 1
Rounds per year 0.05
Lead investments 0
Key employees Soon

Areas of investment

  • Therapeutics
  • Life Science
  • Biotechnology
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of RouteOne:
Typical Co-investors
RouteOne is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after RouteOne:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anhui Huawen Capital Investment Management Anhui, China, Hefei
AppLovin California, Palo Alto, United States
Cheng Tian Capital II China, Hong Kong, Hong Kong Island
Cushman & Wakefield New York, New York, United States
EFG-EG -
Ethos Partners (Singapore) Central, Central Region, Singapore
Gansu Gangtai Holding (Group) China, Shanghai
Goel Fund North Dakota, United States, Williston
Greyhound Capital England, London, United Kingdom
Hindustan Media Venture Delhi, India, New Delhi
Kolibra Capital Indonesia, Jakarta, Jakarta Raya
Kyber Capital -
McGraw Hill Financial New York, New York, United States
Momentum Bioscience England, Reading, United Kingdom
Qianhai Wande Fund China, Guangdong, Shenzhen
Qure HaMerkaz, Israel, Netanya
Research Frontiers New York, United States, Woodbury
Siena Holdings Plano, Texas, United States
Woolworths Limited Australia, New Farm, Queensland
Zhejiang Haining Yingchuang Equity Investment China, Haining, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biopharma
Biotechnology
Life Science
Therapeutics
$125M19 Mar 2021 Bengaluru, Karnataka, India

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent RouteOne?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 125M
Rounds per year 0.05
Peak activity year 2021
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Biopharma
Biotechnology
Life Science
Therapeutics
$125M19 Mar 2021 Bengaluru, Karnataka, India
Crunchbase icon

Content report

The following text will be sent to our editors: